News

Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...
If a routine streamlined a process and passed the common sense test, I was more than happy to adopt it. However, if it caused more harm than good, I took great pride in being able to adapt quickly. In ...
The Very Early Diagnosis of Systemic Sclerosis (VEDOSS) criteria identify red flags as puffy fingers, abnormal nailfold ...
Researchers have developed an innovative new nanopore sequencing assay to identify carriers of fragile X syndrome (FXS), the ...
Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...
Ola Landgren, MD, PhD, shares ADVANCE trial results, which show that adding daratumumab to carfilzomib-lenalidomide-dexamethasone (DKRd) improves outcomes in newly diagnosed multiple myeloma.